Royal Philips: From Medtech Supplier To Health Care Solutions Partner
CEO Frans van Houten On How To Build A Global Healthtech Player For The Future
Executive Summary
Health care delivery has been transformed over the past decade, and so has Royal Philips, whose CEO Frans van Houten explains why both were necessary, and the extra impetus for system-wide change following the COVID-19 pandemic.
You may also be interested in...
Swiss Consult On Local IVDR Until July, EU MRA Awaited Still
A medtech MRA with the EU remains outstanding. Meanwhile Swiss medtech regulations continue to be harmonized with those of the EU in readiness for future mutual recognition.
2021 Opportunities For Healthtech Investment: A Legal Firm’s View
For life sciences investors, the past year has been the busiest period in recent memory, say Goodwin partners Sophie McGrath and David Mardle. But what are the industry's drivers and key investor trends in 2021?
2021 Opportunities For Healthtech Investment: A Legal Firm’s View
For life sciences investors, the past year has been the busiest period in recent memory, say Goodwin partners Sophie McGrath and David Mardle. But what are the industry's drivers and key investor trends in 2021?